Clinical trial
Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
NCT04967807 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
- Lead sponsor
- University Health Network, Toronto
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 5, 2021
- Completion date
- August 5, 2026
- Enrollment
- 57 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac mri, covid-19 vaccination, myocardial injury, myocarditis, sars-cov-2